Real-world use of temsirolimus in Japanese patients with unresectable or metastatic renal cell carcinoma: recent consideration based on the results of a post-marketing, all-case surveillance study

Lignende værker

• A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance
  af: Akaza, Hideyuki, et al.
  Udgivet: (2015)
• Efficacy and safety of sorafenib for advanced renal cell carcinoma: real-world data of patients with renal impairment
  af: Tatsugami, Katsunori, et al.
  Udgivet: (2018)
• Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis
  af: Tatsugami, Katsunori, et al.
  Udgivet: (2018)
• Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
  af: Sato, Kazuo, et al.
  Udgivet: (2018)
• Telomerase Is Upregulated in Irreversible Preneoplastic Lesions during Bladder Carcinogenesis in Rats
  af: Shimazui, Toru, et al.
  Udgivet: (2002)